These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2119665)

  • 41. Repeat infusion of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction and early recurrent myocardial ischemia.
    Barbash GI; Hod H; Roth A; Faibel HE; Mandel Y; Miller HI; Rath S; Zahav YH; Rabinowitz B; Seligsohn U
    J Am Coll Cardiol; 1990 Oct; 16(4):779-83. PubMed ID: 2120309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparison of clinical efficacy of thrombolytic drugs in patients with acute myocardial infarction].
    López-Sendón JL
    Rev Esp Cardiol; 1992; 45 Suppl 2():9-20. PubMed ID: 1475514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of 2 intravenous thrombolytic agents (anisoylated plasminogen streptokinase activator complex versus streptokinase) in patients with acute myocardial infarction.
    Seabra-Gomes R; Aniceto Silva J; Aleixo A; Real T; Freire I; Torres I; Freitas R; Crespo F
    Drugs; 1987; 33 Suppl 3():169-74. PubMed ID: 3315586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Thrombolytic drugs in acute myocardial infarct].
    Ambrosioni E; Degli Esposti D
    Cardiologia; 1991 Dec; 36(12 Suppl 1):395-402. PubMed ID: 1841796
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
    Anderson JL; Rothbard RL; Hackworthy RA; Sorensen SG; Fitzpatrick PG; Dahl CF; Hagan AD; Browne KF; Symkoviak GP; Menlove RL
    J Am Coll Cardiol; 1988 Jun; 11(6):1153-63. PubMed ID: 3284943
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Recurrent ST segment elevations in continuous ECG analysis in the acute phase of myocardial infarct treated with thrombolytic therapy].
    Dissmann R; Jereczek M; Schröder R; Pinkwart L; Völler H; Behrens S; Andresen D; Linderer T
    Z Kardiol; 1994 Jun; 83(6):414-22. PubMed ID: 8067044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravenous streptokinase in evolving acute myocardial infarction.
    Ganz W; Geft I; Shah PK; Lew AS; Rodriguez L; Weiss T; Maddahi J; Berman DS; Charuzi Y; Swan HJ
    Am J Cardiol; 1984 May; 53(9):1209-16. PubMed ID: 6711421
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Streptokinase and recombinant tissue plasminogen activator (rt-PA) are equally effective in treating acute myocardial infarction.
    Sherry S; Marder VJ
    Ann Intern Med; 1991 Mar; 114(5):417-23. PubMed ID: 1899546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gender and acute myocardial infarction: is there a different response to thrombolysis?
    Woodfield SL; Lundergan CF; Reiner JS; Thompson MA; Rohrbeck SC; Deychak Y; Smith JO; Burton JR; McCarthy WF; Califf RM; White HD; Weaver WD; Topol EJ; Ross AM
    J Am Coll Cardiol; 1997 Jan; 29(1):35-42. PubMed ID: 8996292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy.
    Langer A; Krucoff MW; Klootwijk P; Simoons ML; Granger CB; Barr A; Califf RM; Armstrong PW
    J Am Coll Cardiol; 1998 Mar; 31(4):783-9. PubMed ID: 9525547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison between intravenous streptokinase and tissue plasminogen activator with early intravenous heparin in acute myocardial infarction.
    Cherng WJ; Chiang CW; Kuo CT; Lee CP; Lee YS
    Am Heart J; 1992 Apr; 123(4 Pt 1):841-6. PubMed ID: 1549990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efegatran sulfate as an adjunct to streptokinase versus heparin as an adjunct to tissue plasminogen activator in patients with acute myocardial infarction. ESCALAT Investigators.
    Fung AY; Lorch G; Cambier PA; Hansen D; Titus BG; Martin JS; Lee JJ; Every NR; Hallstrom AP; Stock-Novack D; Scherer J; Weaver WD
    Am Heart J; 1999 Oct; 138(4 Pt 1):696-704. PubMed ID: 10502216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reocclusion three months after successful thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activating complex.
    Takens BH; Brügemann J; van der Meer J; den Heijer P; Lie KI
    Am J Cardiol; 1990 Jun; 65(22):1422-4. PubMed ID: 2191581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
    Lundergan CF; Reiner JS; McCarthy WF; Coyne KS; Califf RM; Ross AM
    J Am Coll Cardiol; 1998 Sep; 32(3):641-7. PubMed ID: 9741505
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial.
    Wackers FJ; Terrin ML; Kayden DS; Knatterud G; Forman S; Braunwald E; Zaret BL
    J Am Coll Cardiol; 1989 Apr; 13(5):998-1005. PubMed ID: 2494246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of early thrombolytic therapy (anistreplase versus streptokinase) on enzymatic and electrocardiographic infarct size in acute myocardial infarction. TEAM-2 Investigators.
    Karagounis L; Moreno F; Menlove RL; Ipsen S; Anderson JL
    Am J Cardiol; 1991 Oct; 68(9):848-56. PubMed ID: 1927942
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion.
    Wong CK; French JK; Krucoff MW; Gao W; Aylward PE; White HD
    Eur Heart J; 2002 Sep; 23(18):1449-55. PubMed ID: 12208225
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of early coronary patency on the evolution of myocardial infarction: a prospective arteriographic study.
    Timmis AD; Griffin B; Crick JC; Nelson DJ; Sowton E
    Br Heart J; 1987 Oct; 58(4):345-51. PubMed ID: 3314951
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thrombolytic therapy in selected patients with impending myocardial reinfarction.
    Mendia R; Negrini M; Turazza FM; Lazzaroni A; Palmeri NM; Sanna G
    Coron Artery Dis; 1993 Jul; 4(7):631-6. PubMed ID: 8281367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ratio of ST-segment and myoglobin slopes to estimate myocardial salvage during thrombolytic therapy for acute myocardial infarction.
    Baskin JM; Wilkins ML; Ohman EM; Clemmensen P; Grande P; Christenson RH; Sevilla DC; Wagner NB; Wagner GS
    Am J Cardiol; 1993 Jun; 71(15):1362-5. PubMed ID: 8498383
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.